$1.07 Billion is the total value of HARVARD MANAGEMENT CO INC's 18 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 17.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FB | Buy | FACEBOOK INCcl a | $403,887,000 | +1130.4% | 2,268,011 | +1233.5% | 37.61% | +364.2% |
PANW | Buy | PALO ALTO NETWORKS INC | $265,104,000 | +2309.2% | 1,300,615 | +2308.3% | 24.69% | +809.0% |
BKNG | Buy | BOOKING HLDGS INC | $173,881,000 | +261.3% | 88,597 | +245.1% | 16.19% | +36.3% |
GOOGL | Sell | ALPHABET INCcap stk cl a | $129,554,000 | +6.5% | 106,093 | -5.6% | 12.06% | -59.8% |
IVV | Sell | ISHARES TRcore s&p500 etf | $20,616,000 | -3.1% | 69,061 | -4.3% | 1.92% | -63.4% |
GLD | Sell | SPDR GOLD TRUST | $14,075,000 | +4.1% | 101,355 | -0.1% | 1.31% | -60.7% |
VEA | Sell | VANGUARD TAX MANAGED INTL FDftse dev mkt etf | $12,795,000 | -6.8% | 311,456 | -5.4% | 1.19% | -64.8% |
ADBE | New | ADOBE INC | $11,940,000 | – | 43,222 | +100.0% | 1.11% | – |
QQQ | Buy | INVESCO QQQ TRunit ser 1 | $9,538,000 | +1.2% | 50,517 | +0.1% | 0.89% | -61.8% |
VWO | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $7,558,000 | -5.3% | 187,728 | 0.0% | 0.70% | -64.3% | |
EDV | Sell | VANGUARD WORLD FDextended dur | $7,269,000 | +5.5% | 51,442 | -5.2% | 0.68% | -60.2% |
IJH | Sell | ISHARES TRcore s&p mcp etf | $5,002,000 | -3.8% | 25,885 | -3.3% | 0.47% | -63.7% |
IJR | ISHARES TRcore s&p scp etf | $4,552,000 | -0.6% | 58,484 | 0.0% | 0.42% | -62.5% | |
MGTA | MAGENTA THERAPEUTICS INC | $3,413,000 | -30.4% | 332,610 | 0.0% | 0.32% | -73.7% | |
FULC | New | FULCRUM THERAPEUTICS INCcl a | $2,727,000 | – | 410,714 | +100.0% | 0.25% | – |
NTGN | NEON THERAPEUTICS INC | $870,000 | -63.7% | 505,871 | 0.0% | 0.08% | -86.3% | |
ADRO | ADURO BIOTECH INC | $679,000 | -31.2% | 640,595 | 0.0% | 0.06% | -74.2% | |
VIG | VANGUARD GROUPdiv app etf | $342,000 | +4.0% | 2,858 | 0.0% | 0.03% | -60.5% | |
AAPL | Exit | APPLE INC | $0 | – | -506,683 | -100.0% | -24.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-08
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 34 | Q3 2021 | 19.4% |
VANGUARD TAX-MANAGED INTL FD | 34 | Q3 2021 | 14.0% |
VANGUARD INTL EQUITY INDEX F | 34 | Q3 2021 | 12.2% |
SPDR GOLD TRUST | 34 | Q3 2021 | 8.7% |
ISHARES TR | 34 | Q3 2021 | 4.9% |
META PLATFORMS INC | 29 | Q3 2023 | 37.6% |
VANGUARD SPECIALIZED PORTFOL | 28 | Q1 2020 | 2.8% |
MAGENTA THERAPEUTICS INC | 21 | Q2 2023 | 1.4% |
ALPHABET INC | 19 | Q3 2023 | 30.4% |
ISHARES TR | 19 | Q3 2021 | 4.4% |
View HARVARD MANAGEMENT CO INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NuCana plc | February 12, 2021 | 1,678,239 | 3.3% |
ADURO BIOTECH, INC. | February 08, 2019 | 640,595 | 0.8% |
Fortress Transportation & Infrastructure Investors LLCSold out | July 08, 2016 | 0 | 0.0% |
Alpha Security Group CORP | February 13, 2009 | 436,300 | 5.8% |
BLOCKBUSTER INC | February 13, 2009 | 5,567,100 | 7.7% |
ChinaGrowth North Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
ChinaGrowth South Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
GENEVA ACQUISITION CORPSold out | February 13, 2009 | 0 | 0.0% |
Ideation Acquisition Corp. | February 13, 2009 | 310,200 | 2.5% |
MBF Healthcare Acquisition Corp. | February 13, 2009 | 1,220 | 0.0% |
View HARVARD MANAGEMENT CO INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
13F-HR | 2021-11-12 |
View HARVARD MANAGEMENT CO INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.